December 6, 2016
Toyama Chemical, a Fujifilm group company, said on December 5 that it has initiated a PIII clinical trial for its macrolide antibacterial agent T-4288 (solithromycin) in Japan. Discovered by US antibiotics maker Cempra, T-4288 shows strong antibacterial activity on bacterial...read more